Hepatitis C Medicine

Offering you a complete choice of products which include ribavirin capsules usp 200mg, sofosbuvir 400 mg tablets, myhep lvir tablet, mydekla 60 mg tablets, hepcinat plus tablets and velpaclear sofosbuvir velpatasvir tablets.

Ribavirin Capsules Usp 200mg

Request Callback

₹ 800 Get Latest Price

Strength200 mg
CompositionRibavirin (200mg)
Prescription/Non prescriptionPrescription
FormCapsule
Storage ConditionStore below 30 DegreeC
Ribavirin 200mg Capsule is an antiviral medicine that is used in the treatment of chronic hepatitis C virus (HCV) infection. It prevents the multiplication of virus in human cells and clears up the infection.

Sofosbuvir 400 Mg Tablets

Request Callback

₹ 12000 Get Latest Price

Dose/Strength400 mg
Packaging TypeBottle
CompositionSofosbuvir (400mg)
Prescription/Non prescriptionPrescription
FormTablet
MY Hep 400mg Tablet is an antiviral medication. It is used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection. It works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time.

Myhep Lvir Tablet

Request Callback

₹ 16000 Get Latest Price

Packaging Size1*28
CompositionLedipasvir (90mg) + Sofosbuvir (400mg)
Prescription/Non prescriptionPrescription
FormTablet
ManufacturerMylan Pharmaceuticals Pvt Ltd - A Viatris Company
Myhep Lvir Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection.

Mydekla 60 Mg Tablets

Request Callback

₹ 5000 Get Latest Price

Dose/Strength60 mg
CompositionDaclatasvir (60mg)
Packaging TypeStrip
BrandMylan
Prescription/Non prescriptionPrescription
FormTablet
Mydekla 60 Tablet is an antiviral medication. It is used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection.

Hepcinat Plus Tablets

Request Callback

₹ 17500 Get Latest Price

Packaging SizeBox
CompositionDaclatasvir (60mg) + Sofosbuvir (400mg)
Drug NameHepcinat Plus 60mg/400mg Tablet
Prescription/Non prescriptionPrescription
FormTablet
ManufacturerNatco Pharma Ltd
Hepcinat Plus 60mg/400mg Tablet is a combination medicine used in the treatment of chronic hepatitis C virus (HCV) infection. It works by reducing the number of hepatitis C viruses in the body and removing the virus from the blood over a period of time.

Velpaclear Sofosbuvir Velpatasvir Tablets

Request Callback

₹ 17500 Get Latest Price

Strength400 mg+ 100 mg
CompositionSofosbuvir (400mg) + Velpatasvir (100mg)
Prescription/Non prescriptionPrescription
FormTablet
Storage ConditionStore below 30 DegreeC
Velpaclear Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection.

Sofosbuvir Velpatasvir Tablets

Request Callback

₹ 17500 Get Latest Price

Strength400 mg+ 100 mg
CompositionSofosbuvir (400mg) + Velpatasvir (100mg)
Prescription/Non prescriptionPrescription
FormTablet
Storage ConditionStore below 30 DegreeC
Velpanat Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection.

Dacihep 60 Mg Tablet

Request Callback

₹ 5606 Get Latest Price

Dose/Strength60 mg
Packaging TypeStrip
CompositionDaclatasvir (60mg)
Prescription/Non prescriptionPrescription
FormTablet
Dacihep 60mg Tablet is an antiviral medication. It is used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection.

Hepcdac 60mg Tablet

Request Callback

₹ 5592 Get Latest Price

Dose/Strength60 mg
CompositionDaclatasvir (60mg)
Prescription/Non prescriptionPrescription
FormTablet
Storage ConditonStore below 30 DegreeC
Hepcdac 60mg Tablet is an antiviral medication. It is used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection.

Mydekla 60 Mg Tablets

Request Callback

₹ 5000 Get Latest Price

Dose/Strength60 mg
CompositionDaclatasvir (60mg)
BrandMylan
Prescription/Non prescriptionPrescription
FormTablet
Mydekla 60 Tablet is an antiviral medication. It is used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection.

Hepcinat Sofosbuvir 400 Mg Tablet

Request Callback

₹ 15000 Get Latest Price

Manufactured ByNatco Pharma Ltd
Packaging Size1*28
CompositionSofosbuvir (400mg)
Prescription/Non prescriptionPrescription
Storage ConditionStore below 30 DegreeC
Hepcinat Tablet is an antiviral medication. It is used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection. It works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time.

Velasof Sofosbuvir 400 Mg Velpatasvir 100 Mg Tablet

Request Callback

₹ 8759 Get Latest Price

CompositionSofosbuvir 400mg ,velpatasvir 100mg
TreatmentTo treat chronic hepatitis C (HCV) infection
Prescription/Non prescriptionPrescription
FormTablet
ManufacturerHETERO HEALTHCARE LTD

Velasof tablet contains the active components Sofosbuvir and Velpatasvir.  It is used to treat chronic hepatitis C. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). The treatment duration is often shorter than older treatment regimens. The duration can vary depending on factors such as HCV genotype, previous treatment history, and the presence of liver cirrhosis. Successful treatment with Velasof tablet can significantly reduce liver inflammation and fibrosis caused by HCV infection. By achieving viral eradication, the risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer) can be substantially reduced.

If you have a known allergy or hypersensitivity to Velasof tablet or any of the components of the medication, you should not take it. The safety and efficacy of sofosbuvir and velpatasvir combination therapy have not been established in children under 18. Its use in the pediatric population is currently limited. It is recommended to use alternative treatment options or adjust the dosage in these cases. 

X

Contact Us

Kundan Bhimte (CEO)
Jagruti Global
Plot No 13, Prince Society, Wathoda Lay Out, Harisson Celebration Lawn, Wathoda, Nagpur - 440008, Maharashtra, India

Get Directions
Send Email
Share: